Real-World Effects and Utilisation Patterns of Elexacaftor, Tezacaftor, and Ivacaftor Combination Therapy (ELX/TEZ/IVA) in Patients with Cystic Fibrosis (CF) First published 15/09/2021 Last updated 02/02/2026 EU PAS number:EUPAS43022 Study Ongoing